These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9841039)

  • 1. Use of calcium channel blockers and risk of suicide. Drug perscriptions over longer period should have been followed up.
    Wiholm BE; Sundström A; Alfredsson L
    BMJ; 1998 Oct; 317(7165):1076-7. PubMed ID: 9841039
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of calcium channel blockers and risk of suicide. Perscriptions for particular drug are influenced by numerous factors.
    Chen YT; Makuch RW
    BMJ; 1998 Oct; 317(7165):1077. PubMed ID: 9841040
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of calcium channel blockers and risk of suicide. Independent studies are needed before causality is established.
    Bergman U; Isacsson G
    BMJ; 1998 Oct; 317(7165):1076. PubMed ID: 9774303
    [No Abstract]   [Full Text] [Related]  

  • 4. Suicide link with blood pressure drug unproven.
    Health News; 1998 Apr; 4(5):7. PubMed ID: 9563303
    [No Abstract]   [Full Text] [Related]  

  • 5. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
    Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
    Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The safety of Calcium channel blockers].
    Leinonen H
    Duodecim; 1996; 112(21):1961-2. PubMed ID: 10605196
    [No Abstract]   [Full Text] [Related]  

  • 9. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.
    Sørensen HT; Czeizel AE; Rockenbauer M; Steffensen FH; Olsen J
    Acta Obstet Gynecol Scand; 2001 May; 80(5):397-401. PubMed ID: 11328214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purpura and bleeding due to calcium-channel blockers: an underestimated problem? Case reports and a pilot study.
    Cox NH; Walsh ML; Robson RH
    Clin Exp Dermatol; 2009 Jun; 34(4):487-91. PubMed ID: 19094124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid personality disorder predicts suicide after major depression: a 10-year follow-up.
    Hansen PE; Wang AG; Stage KB; Kragh-Sorensen P;
    Acta Psychiatr Scand; 2003 Jun; 107(6):436-40. PubMed ID: 12752020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-channel blockade and depressive illness.
    McAllister-Williams RH
    Br J Psychiatry; 1990 Oct; 157():618-9. PubMed ID: 1966676
    [No Abstract]   [Full Text] [Related]  

  • 13. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dental changes in patients treated with calcium antagonists].
    Ivanova S; Kiselova-Ianeva A; Dimitrov L; Stanchev N
    Vutr Boles; 1999; 31(4):41-4. PubMed ID: 10989674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of gastrointestinal haemorrhage with calcium antagonists.
    Desboeuf K; Lapeyre-Mestre M; Montastruc JL
    Br J Clin Pharmacol; 1998 Jul; 46(1):88-9. PubMed ID: 9690957
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.
    Yasar S; Corrada M; Brookmeyer R; Kawas C
    Neurobiol Aging; 2005 Feb; 26(2):157-63. PubMed ID: 15582745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective predictors of suicide attempts in borderline personality disorder at one, two, and two-to-five year follow-up.
    Soloff PH; Fabio A
    J Pers Disord; 2008 Apr; 22(2):123-34. PubMed ID: 18419233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tocolysis with calcium-channel blockers and intraventricular hemorrhage].
    Nguon B; Zupan-Simunek V; Audibert F; Preaux N
    J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):287-92. PubMed ID: 17395401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.